MedPath

Clinical Study of Single Incision Laparoscopic Cholecystectomy in the Treatment of Patients With Acute Cholecystitis

Not Applicable
Recruiting
Conditions
Cholecystectomy, Laparoscopic
Interventions
Procedure: Open cholecystectomy
Registration Number
NCT06074679
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Brief Summary

Gallstone is a common disease in China.At present, the prevalence of gallstones in China is 15 %, and about 210 million people are sick. Acute cholecystitis is acute gallbladder inflammation, is one of the main complications of cholelithiasis or gallstones. The removal of gallbladder and gallstones in patients with acute cholecystitis in the presence of biliary pain will prevent the recurrence of gallbladder and reduce the risk of cholecystitis progression. If gallbladder perforation is not treated in time, the mortality rate is 30 %. Acute acalculous cholecystitis without treatment will be life-threatening, with a mortality rate of up to 50 %. At present, the vast majority of patients with acute cholecystitis are treated with 4-hole traditional laparoscopic cholecystectomy and open cholecystectomy. Their postoperative quality of life, pain and scar-related complications, remain major factors for patients.In recent years, with the renewal of the concept of minimally invasive surgery and the continuous advancement of instruments and technology, single-incision laparoscopic cholecystectomy has also maximized the quality of life after surgery and reduced postoperative pain and scar-related complications. At present, there are few reports on randomized controlled clinical trials of SILC in patients with acute cholecystitis, and there is a lack of large sample size studies.Due to the difficulty of SILC operation, the longer learning curve, the different equipment conditions and technical characteristics of each center, and the lack of standardized training, there is no effective consensus on the application indications and operation procedures of SILC in acute cholecystitis surgery. Based on the current status, the purpose of this study was to investigate the effect of SILC on postoperative quality of life, postoperative pain, scar assessment and postoperative complications in patients with acute cholecystitis, so as to propose a standardized single incision laparoscopic operation procedure in the treatment of acute cholecystitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
600
Inclusion Criteria
  • Acute cholecystitis(GradeⅠ,II)
Exclusion Criteria
  • Combined with liver cirrhosis (Child grade B and above)
  • Upper abdominal surgical history;
  • Changes in surgical plan (conversion to laparotomy,cholangiography, bile duct exploration, bile duct injury repair, abscess clearance, multivisceral resection.)
  • Patients and their families do not agree with the treatment lost follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Single-incision laparoscopic cholecystectomyOpen cholecystectomySILC was defined as laparoscopic surgery done through a single trans-umbilical incision
Conventional laparoscopic cholecystectomyOpen cholecystectomyCLC was defined as three or four port surgery carried out with either French or American position.
Primary Outcome Measures
NameTimeMethod
Quality of life (time to return to normal life)3 years

The quality of life of patients after operation was investigated by a unified SF-36 questionnaire. The higher the final score, the better the quality of life.

Secondary Outcome Measures
NameTimeMethod
Cosmetic result3 years

Evaluation of postoperative incisional scarring using the Vancouver Scar Scale. The lower the score, the higher the scar satisfaction.

Trial Locations

Locations (5)

Changxing Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University

🇨🇳

Huzhou, Zhejiang, China

Shexian Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University

🇨🇳

Huangshan, Anhui, China

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

🇨🇳

Hangzhou, Zhejiang, China

Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University

🇨🇳

Jiande, Zhejiang, China

Suichang Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University

🇨🇳

Lishui, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath